EuroAPI Header EuroAPI Header

X
[{"orgOrder":0,"company":"Bioved Pharmaceuticals","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Bioved Pharmaceuticals Granted a US Patent for Its Oral, Natural Plant-Based Product, Artovid-20\u00ae for The Treatment Of COVID-19","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Approved","country":"U.S.A","productType":"Small molecule","productStatus":"Approved","date":"April 2023","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals by Bioved Pharmaceuticals

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            ARTOVID-20™ (ashwagandha root extract) is a proprietary oral dietary supplement that helps boost immunity. It may help reduce the duration of illness and severity of symptoms reagrding Covid-19 infection.

            Lead Product(s): Ashwagandha Root Extract,Ginger extract,Turmeric Root Extract

            Therapeutic Area: Infections and Infectious Diseases Product Name: ARTOVID-20

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable April 25, 2023

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Post Enquiry
            POST ENQUIRY